CRF

Related by string. CRFS . CRFs * * Honda CRF . CRF receptors . CRF antagonists . report forms CRFs . Honda CRF #R *

Related by context. All words. (Click for frequent words.) 53 CRF antagonists 50 corticotropin releasing factor 49 corticotrophin releasing factor 45 Urocortin 2 45 eDiary 45 Acute Liver Failure 44 SMRI 44 SERCA2a 44 CRFs 44 AGRE 44 mesolimbic 43 experimental allergic encephalomyelitis 43 Cystinosis Research Foundation 43 CALGB 43 CGRP 43 MMRC Member 43 DFCI 43 allergic airway inflammation 43 PU.1 43 ASSERT 43 Randomized Evaluation 43 Mutation Analysis 43 RE LY ® 43 ONTARGET R 42 NMDA 42 somatostatin 42 Stroke NINDS 42 contractility 42 chromatin modifying 42 inosine 42 PhG alpha 1 42 receptor antagonism 42 DF HCC 42 Vasopressin 42 vasopressin receptor 42 Multicenter Automatic Defibrillator Implantation 42 PRIALT 42 sGC 42 Aldosterone 42 PGRN 42 Spine Patient Outcomes 42 thyrotropin 42 PEDF 42 FoxP3 42 Calamity Relief Fund 42 donepezil Aricept 42 NIH SBIR 42 polyamine 42 Acute Decompensated Heart Failure 42 subcutaneous immunoglobulin 42 Prolactin 42 ACh 42 Diabetic Neuropathy 42 BALF 42 Immune Therapy 42 Acute Stroke 41 trodusquemine 41 Artificial Pancreas Project 41 Comorbidity 41 LUMINATE 41 CD#L 41 MSKCC 41 endogenous opioid 41 NeuroStar TMS Therapy 41 multicenter placebo controlled 41 Antithrombin 41 DBMD 41 Phase IIB 41 ABL1 41 melanocortin receptor 41 Bipolar Disorders 41 Adverse Event 41 Ischemic 41 catecholamine 41 Privigen 41 NECCS 41 HPA axis 41 Kahalalide F 41 experimentally induced 41 IL 1ß 41 hepatic stellate cells 41 CHAMPION PCI 41 Nav#.# 41 dopamine signaling 41 Acute Treatment 41 FASN 41 STRIDE PD 41 Tumor Response 41 Endometrial Regenerative Cells 41 OncoGel 41 intravenous tissue plasminogen 41 bone marrow stromal cells 41 Glatiramer acetate 41 NABTT 41 Amino acid 41 Nonclinical 41 vitro pharmacology 41 Glypromate 41 NINDS 41 NeuroSTAT ® 41 Aquinox 41 Chemokine 41 adipose derived regenerative 41 cardiac contractility 41 Myoblast 41 NeoMed 41 MIST II 41 BioZone Laboratories 41 c Fos 41 factor BDNF 41 CTx 41 ProMune 41 eCRF 40 Nuclear Receptors 40 extracellular dopamine 40 TGF beta1 40 transgenic mouse models 40 BCIRG 40 Developmental Therapeutics 40 tramiprosate 40 ACTIVE W 40 OvaRex MAb 40 Steven Tregay 40 HYCAMTIN 40 glucocorticoid induced 40 Src kinases 40 ZFP TF 40 neuropathologic 40 mGluR2 NAM 40 Adult Growth Hormone 40 recombinant erythropoietin 40 retinoid X 40 ReN# 40 serum GGT 40 RhuDex 40 PPARγ 40 MADIT II 40 SUTENT ® 40 DECIPHER 40 ACRIN 40 intracellular Ca 2 40 thrombin receptor 40 FasL 40 Renal Insufficiency 40 transgenic mouse model 40 CSF 40 rhGH 40 plasmid encoding 40 Onconase 40 PRADAXA 40 FUS1 40 visceral adiposity 40 Current Controlled Trials 40 IMP# 40 triglyceride lowering 40 hormone angiotensin II 40 CALGB # [002] 40 Akt phosphorylation 40 mesenchymal stem cell 40 induced phosphorylation 40 myoblast 40 aminotransferase 40 osteoblast 40 Zonisamide 40 baroreflex 40 capillary density 40 aurora kinase 40 tipifarnib 40 HuMax 40 plasma fibrinogen 40 reteplase 40 IGFBP 3 40 Anticalin ® 40 monocytes macrophages 40 recombinant albumin 40 conjugated estrogens 40 Acute Ischemic Stroke 40 Transcription Factor 40 isoproterenol 40 Viramune ® 40 ADAGIO study 40 BCRP 40 genetically altered mouse 40 Onconova 40 Phase IIA 40 GH secretion 40 serotonin 2A 40 PABI Plan 40 BIIR 40 busulfan 40 GAD# 40 IDIS 40 COPERNICUS 40 ADHERE 40 lipoic acid 40 TRANSCEND 40 von Willebrand factor 40 VAPRISOL 40 darbepoetin alpha 40 TGF β1 40 Dual Antiplatelet Therapy 40 RE LY 40 EORTC 40 PHT LogPad 40 TargeGen 40 LIF 40 ABCB1 40 POMC 40 mITT population 40 immunotoxicity 40 multicenter randomized controlled 40 cardiac troponin 40 Exer Rest R 40 Oxidized LDL 39 Hematopoietic Stem Cells 39 FSH receptor 39 BEXXAR Therapeutic Regimen 39 activating mutation 39 Investigator Initiated 39 TNF receptor 39 ENGAGE AF TIMI 39 Glycosylation 39 NKT cell 39 PPID 39 incretin 39 Monocyte 39 transferases 39 Factor VIIa 39 NKX#.# 39 db db mice 39 Fibroblast 39 EAAT2 39 Judith Hochman 39 Acthar Gel 39 Ancrod 39 LHRH agonists 39 adult mesenchymal stem 39 Trandolapril 39 neuronal differentiation 39 Immune Tolerance 39 Multiple Myeloma MM 39 Phase Forward InForm 39 striatal dopamine 39 Fillanthropy Program 39 FKBP# 39 PC# cells 39 PDE# inhibitors 39 rHuPH# 39 Experimental Therapeutics Program 39 XBP 1s 39 Chronic Renal Failure 39 skeletal muscle cells 39 Angiotensin II 39 HIF 1a 39 medial frontal cortex 39 GW# [003] 39 Paion 39 ERK1 2 39 dopamine synthesis 39 Viralytics 39 hematological parameters 39 ISTODAX 39 translational research 39 SANVAR 39 oocytes retrieved 39 CoAxia 39 placebo controlled clinical 39 dobutamine 39 PBMCs 39 TRAF6 39 PREVENT IV 39 arcuate nucleus 39 HPRT 39 SOCS3 39 selective inhibition 39 lactate dehydrogenase LDH 39 Hematopoietic 39 C#BL 6 mice 39 Stromal 39 Ischaemic 39 Biological Passport 39 Main Outcome Measure 39 NIAMS 39 circadian genes 39 Serious Adverse Events 39 Bupropion 39 Optivia Biotechnology 39 Clinical Outcome 39 Ocrelizumab 39 Vernakalant 39 transgenic mice expressing 39 FXIII 39 REMINYL ® 39 iPS derived 39 GSK# [001] 39 PRF 39 cardiogenic 39 cardiomyocyte 39 serum IGF 39 antiproliferative effects 39 Etanercept 39 hepatoma 39 GEMS TM 39 Heritability 39 neuro endocrine 39 nicotinic receptor 39 Human Pluripotent Stem 39 poly ICLC 39 MyoCell ® 39 RSRF 39 ePRO solutions 39 Degarelix 39 VIDA Diagnostics 39 BUSM 39 dose dependently 39 redox active 39 NYHA functional class 39 P#X# 39 Recombinant Human 39 Thorough QT 39 cathepsin K inhibitor 39 SCIg 39 Genetic Therapy 39 NICE SUGAR 39 leukocyte count 39 Erythropoietic 39 hematopoietic 39 Allogeneic 39 Multiple Ascending Dose 39 caveolin 1 39 Trodusquemine 39 GPI anchored 39 Transmax 39 REGEN trial 39 Pediatric Hematology Oncology 39 Medidata Grants Manager 39 Prospective Randomized 39 SWOG 39 PTMA 39 carcinoembryonic antigen 39 Therapy Evaluation 39 tachyarrhythmia 39 Pharmacokinetic studies 39 euthymic patients 39 soluble receptor 39 annexin 39 Chronic Heart Failure 39 procaspase 3 39 factor Xa inhibitor 39 motor neuron degeneration 39 A1PI 39 NSABP 39 cAMP dependent 39 triiodothyronine 39 Cipralex ® 39 renal fibrosis 39 Dysregulation 39 transcranial Doppler ultrasound 39 Cardiorespiratory 39 E2B 39 sd rxRNA 39 serotonin norepinephrine 39 hENT1 39 pretransplant 39 Wnt signaling 39 foveal thickness 39 prion protein PrP 39 CXCR4 expression 39 FGF2 39 paricalcitol 39 LIPO 39 ACCORD Lipid 39 BMP signaling 39 AAEP Foundation 39 IGFs 39 ISTH 39 Technosphere ® 39 oncomodulin 39 Neuraltus 39 ALB # 39 ERalpha 39 MyoD 39 fast skeletal troponin 39 multicentre phase 39 Cardiac Outcomes 39 Soluble CD# 39 Clinical Trials Consortium 39 epoetin alpha 39 SCD1 39 UroVysion 39 glycogen metabolism 39 ToGA 39 Circulatory Support 39 pDCs 39 Corgentin 39 murine mouse 39 PPARs 39 neuroregenerative 39 S#A# [002] 39 WBPA 39 Angiogenic 39 CDISC ODM 39 GWTG 39 Amorcyte 39 adrenocortical 39 NART 39 NIH 39 TMS Therapy 39 glucocorticoid receptor 39 Aggrenox ® 39 beta2 39 EGFR signaling 39 monocyte chemoattractant protein 39 pharmacokinetic characteristics 39 nitric oxide synthase NOS 39 mu opioid 39 Exforge HCT 39 cardiac conduction 39 TRAIL induced apoptosis 39 serotonin reuptake inhibitor 39 BiTE 39 HUCB cells 39 Levacor 38 MoxDuo IR 38 C3A 38 LAB CGRP 38 hMG 38 Dilated Cardiomyopathy 38 Nocturia 38 c fos 38 Healthcare Improvement IHI 38 Catheter Associated 38 PTHrP 38 recombinant FVIII 38 lowers blood glucose 38 ACE Inhibitor 38 FK# 38 selective adenosine 38 GCP 38 Hypoxia Inducible Factor 38 Desferal 38 CHARM Added 38 histone acetylation 38 Transcranial Magnetic Stimulation TMS 38 Norepinephrine 38 Anticancer Agents 38 GISSI HF 38 Gemin X 38 everolimus eluting stents 38 SYGNIS 38 mdx mouse 38 glutamatergic neurons 38 NTx TM -# 38 cells MSCs 38 MDRs 38 heFH 38 Lp PLA 2 38 Adult Stem Cell Therapy 38 rHuEPO 38 citicoline 38 adipogenic 38 Azacitidine 38 Translational Science Award 38 RE MODEL 38 adiponectin concentrations 38 BCNS 38 CYP #D# 38 Accelerated Cure 38 TrkB 38 abacavir Ziagen 38 PhytoMedical 38 vasoactive 38 Interferon Beta 38 Reata Pharmaceuticals 38 anti Parkinsonian 38 Pulmonary Arterial Hypertension 38 VEGF Trap 38 randomized discontinuation 38 GABAA receptor 38 Creabilis Therapeutics 38 Bipolar Mania 38 functional electrical stimulation 38 Artificial Cornea 38 Shc 38 Dr. Beilharz 38 CRCs 38 decellularized 38 Alzheimer Disease Cooperative 38 proinflammatory mediators 38 vascular reactivity 38 Varenicline 38 endocannabinoid signaling 38 Echocardiographic 38 OvaDx 38 breast epithelial cells 38 p#Kip# 38 Aranesp darbepoetin alfa 38 IMC #B 38 AstraZeneca Targacept 38 peripheral insulin sensitivity 38 uridine 38 PrecisionMed 38 SGLT2 inhibitors 38 transgenic rats 38 TLE3 38 Asthma Intervention 38 Cell Signaling 38 InterHealth 38 Ca2 + 38 muscarinic receptors 38 mediated inhibition 38 ERK signaling 38 RARP 38 LogPad 38 antihypertensive medicines 38 alteplase 38 Preclinical Study 38 C5aR 38 pDC 38 r hGH 38 Metabolic Disease 38 cardiac valvulopathy 38 ONTARGET 38 Angioblast Systems 38 embryonal carcinoma 38 focal adhesion 38 P2X 38 immunostaining 38 plasminogen activator 38 TRX4 38 Lysis 38 kappa B 38 INTERCEPT treated 38 Myelodysplastic Syndrome MDS 38 motesanib diphosphate 38 Proliferative 38 MEND CABG II 38 androgen receptor AR 38 hexose 38 microplasmin Phase III 38 Neurobiological 38 Phase Ib clinical 38 pharmacokinetic PK 38 eprodisate Fibrillex TM 38 5 HT1A 38 E selectin 38 splenocytes 38 Cardiometabolic Risk 38 Patient Navigation 38 Brd4 38 BNC# 38 GWTG CAD 38 PD2i ® 38 Symptom Severity 38 Pentraxin 2 38 IRSF 38 Survivorship Program 38 Sir2 38 Simulect 38 Central Venous Catheter 38 Tumor Sequencing Project 38 COSTAR II 38 Myozyme alglucosidase alfa 38 Fabry Disease 38 Small Modular SMIP 38 salivary cortisol 38 recurrent glioblastoma multiforme 38 Oncogenic 38 Trophos 38 HF ACTION 38 PROTEGE 38 Tamas Bartfai 38 Stemulite ™ Fitness 38 iPSC derived 38 Versartis 38 Valdoxan 38 GELA 38 transcriptional profiles 38 inflammatory demyelinating 38 TNF Alpha 38 DeveloGen 38 iron chelators 38 JAK3 38 NIH NHLBI 38 Squalamine 38 OPTIMIZE HF 38 Acute Coronary Syndromes ACS 38 Interferon beta 38 Prolongs Survival 38 tryptophan hydroxylase 38 FDA Investigational Device 38 orthotopic 38 infarcted myocardium 38 TriRima 38 Estradiol 38 Clinical Practice Guidelines 38 sargramostim 38 microglial activation 38 beta amyloid peptides 38 Cardiometabolic 38 pancreatic ductal 38 Serum HER-2/neu Test 38 tau phosphorylation 38 Memory Impairments 38 erythropoietic 38 PYY #-# 38 biphasic 38 prostate carcinogenesis 38 E1 INT TM 38 PDE1 38 Hydroxyurea 38 genetic loci 38 ventricular myocardium 38 plasma albumin 38 Androxal TM 38 vWF 38 glucose transporter 38 physiologically relevant 38 MELD 38 D aspartic acid 38 MMRC 38 Onconova Therapeutics Inc. 38 RLTAP 38 selective agonists 38 SREBP 1c 38 inotropic 38 follitropin alfa 38 pancreatic islet 38 cystatin 38 P2Y 38 NTx 38 autologous cultured chondrocytes 38 Indirect Costs 38 aggregated Abeta 38 BGM Galectin 3 38 CD# monoclonal antibody 38 Neoadjuvant 38 Adrenergic 38 CEACAM1 38 Optivia 38 erlotinib Tarceva 38 Recombinant 38 Meta analyzes 38 fosbretabulin 38 transfected cells 38 uPA 38 glucokinase 38 microdose 38 Beta catenin pathway 38 Antiangiogenic 38 TIMP 1 38 Quinamed 38 HSP# inhibitors 38 multicenter prospective 38 plasminogen activator inhibitor 38 Tapentadol 38 pro angiogenic 38 lutropin alfa 38 glucose homeostasis 38 Innate Immune 38 naltrexone implant 38 telomere dysfunction 38 leukocyte 38 glulisine 38 NGF 38 CIMZIA TM 38 CTSAs 38 PNA FISH TM 38 affective disorders 38 irbesartan 38 PSVT 38 StAR 38 leader Hakon Hakonarson 38 relapsed MM 38 Adrenomyeloneuropathy AMN 38 Wellmune WGP 38 Urocidin TM 38 NIDCR 38 Nitric oxide NO 38 bisoprolol 38 CHD5 38 SSRI paroxetine 38 methylnaltrexone 38 Cardiomyocytes 38 HIV lipodystrophy 38 DiscoveryBioMed 38 acting inhaled anticholinergic 38 CCMR 38 MabThera rituximab 38 dietary carbohydrate 38 adenovirus vectors 38 Enzastaurin 38 Cogane 38 BioMarker 38 colonic mucosa 38 induced apoptosis 38 NP2 Enkephalin 38 vasopressin 38 BDNF gene 38 nephrogenic 38 EGFR HER2 38 Radiation Therapy Oncology 38 GISSI 38 selective A1 adenosine 38 AMD# [003] 38 beta adrenergic receptors 38 Vidofludimus 38 38 Galectin 3 38 Risk Stratification 38 thioester 38 #p# [003] 38 XBP1 38 Foxp3 38 Xeomin ® 38 PROCRIT R 38 TNFα 38 prospective nonrandomized 38 CRF1 38 Cardiotoxicity 38 ESPS 38 NK1 38 Kidney Disease Outcomes 38 Almorexant 38 adrenocorticotropic hormone 38 opioid naïve 38 Monoclonal antibody 38 TGF alpha 38 codon usage 38 vidofludimus 38 MADIT 38 Rs.#.# lakh [005] 38 Differentially 38 5 HT4 receptor 38 Investigational Treatment 38 Clinicaltrials.gov 38 Inosine 38 pharmacologic stress testing 38 Ovarian Cancer Screening 38 Xcellerated T Cells 38 Vivaglobin 38 PI3K Akt 38 bioavailable testosterone 38 Reeve Irvine 38 Metabolic Disorder 38 urokinase plasminogen activator 38 Teriflunomide 38 Nicotinamide 38 BETAS 38 5 HT1A receptor 38 PBTF 38 prospective multicentre 38 locomotor activity 38 Hypogonadism 38 DAPT 38 pharmacodynamic PD 38 FHCRC 38 Cyclin D1 38 Defibrillation 38 ischemia reperfusion 38 reboxetine 38 CATIE AD 38 Val HeFT 37 drug metabolizing enzymes 37 briakinumab 37 Dabigatran etexilate 37 LT NS# 37 TRIF 37 Related Mortality 37 endocannabinoid 37 Neupogen ® 37 EURIDIS 37 tubular atrophy 37 Fas ligand 37 PrivateRaise.com 37 Choroidal Neovascularization 37 DEFINITY R 37 Kenta Biotech 37 airway hyperresponsiveness 37 GPIIb IIIa 37 Glucosamine chondroitin Arthritis 37 hemichannels 37 neurohormones 37 Intervention Trial GAIT 37 AHEI 37 daily subcutaneous injections 37 TRO# 37 FAMPYRA 37 Cell Transplant 37 Ischemia 37 cytochrome p# 37 microRNA miR 37 peginesatide 37 PPAR γ 37 ON #.Na 37 KLF4 37 Ceplene/IL-2 37 PACAP 37 Pharmacogenetics 37 Kinoid 37 HepG2 cells 37 syngeneic 37 BMPR2 37 Internally Generated Funds 37 sibutramine Meridia 37 amylin 37 Arterial Hypertension 37 arachidonic acid AA 37 phosphorylated tau 37 MetAP2 37 GPR# [001] 37 Excretion 37 immune modulating 37 ancrod 37 TURNS Treatment 37 lysophosphatidic acid LPA 37 cholinergic tone 37 mecamylamine 37 GSK Oncology 37 CpG ODNs 37 37 lung fibrosis 37 HFN database 37 receptor agonist 37 trophoblast cells 37 ORTHO 37 malondialdehyde 37 glutamate 37 Insulin detemir 37 recombinant plasma 37 desmopressin acetate 37 epoetin alfa 37 mediated phosphorylation 37 FORTIS M 37 GG genotype 37 IFN alpha 2a 37 REVEAL Registry 37 6 OHDA 37 astressin B 37 tumor specific antigen 37 CDRF 37 Cognitive Deficits 37 RNase L 37 employeesâ € ™ 37 theta rhythm 37 NCIC CTG 37 NEVO RES 37 adrenocortical cancer 37 Cellular Therapy 37 Piomelli 37 Immune Monitoring 37 clonogenic 37 NN# [001] 37 Optimata 37 IFN g 37 Human Hookworm Vaccine Initiative 37 REGENESIS Phase IIb 37 Tyrima 37 Microdosing 37 SYMMETRY trial 37 NKI AVL 37 Reaxys 37 kalirin 37 Anticalins ® 37 Malenka 37 ACCORD Eye 37 QTc intervals 37 JAK2 V#F 37 NS5A 37 Translational Science Awards 37 gamma secretase inhibitor 37 Longevinex R 37 triggers apoptosis 37 Fibrinogen 37 Cytochrome P# 37 EcoNugenics 37 hedgehog signaling pathway 37 nigrostriatal 37 Cogentus 37 National Institutes 37 prospectively enrolled 37 effector function 37 TrialMaster 37 glucocorticoid receptor GR 37 colorectal carcinoma 37 corticotrophin releasing hormone 37 Dendritic cell 37 ATG#L# 37 cyclophilin D 37 prucalopride 37 LEAPS H#N# 37 gemtuzumab ozogamicin 37 Intra Cellular Therapies 37 GLI1 37 ORWH 37 SRF 37 protein tyrosine phosphatase 1B 37 cardiac myocytes 37 urinary cortisol 37 APAF 37 Introgen ADVEXIN 37 Posiphen 37 Prognostic significance 37 5HT 37 Drug Coated Coronary 37 JDRF 37 ECASS 37 number NCT# ClinicalTrials.gov 37 C1 Inhibitor 37 dopamine receptors 37 #β estradiol 37 tipranavir 37 riociguat 37 activating receptors 37 BCL2 37 Progesterone 37 Muscarinic 37 Adenoma Prevention 37 #beta HSD1 37 secretagogues 37 hypoxia inducible transcription 37 acute humoral rejection 37 BeneFIX 37 Androgen 37 rFSH 37 protein tyrosine phosphatase 37 microsomal 37 plasma renin activity 37 dopaminergic 37 hepatocellular carcinoma liver 37 Teriparatide 37 OncoVex 37 Avemar 37 rFVIII 37 Multiple Myeloma Research 37 JAK2 inhibitor 37 K DOQI 37 hepatic glucose production 37 ADMIRE HF 37 YONDELIS 37 aleglitazar 37 Viprinex 37 TNF antagonist 37 GABAergic interneurons 37 Clinic Taussig Cancer 37 vitro cytotoxicity 37 platelet dysfunction 37 myocardial contractility 37 Musculoskeletal Diseases 37 IL 1β 37 GI motility disorders 37 LEUKINE 37 MIVI TRUST 37 Serdolect ® 37 CTGF 37 IGSP 37 Aquapheresis 37 GCN2 37 Intervention Trial 37 serotonin reuptake inhibition 37 anterior pituitary 37 Patient Reported Outcomes 37 Therapeutic Advances 37 repolarization 37 cardiac repolarization 37 ischemia induced 37 pertussis toxin 37 ALISTA 37 ibandronate 37 phase IIa clinical 37 Genetic variants 37 Losartan 37 ADNI 37 GnRH 37 Hans Keirstead 37 Certican 37 Glioma 37 ALDH 37 NR2B subunit 37 calcineurin 37 von Willebrand 37 sCD# 37 ePRO 37 IGF 37 Gynecologic Oncology Group 37 Ziprasidone 37 myogenic 37 CsA 37 polyamines 37 Platelet 37 Schizophrenia Treatment 37 KINAXO 37 SSRI citalopram 37 CD4 CD8 37 bronchial epithelial cells 37 Serious Adverse Event 37 endometrial stem cells 37 Human Neural Stem 37 Rilonacept

Back to home page